5051 POSTER First-line Bevacizumab Plus
5051 POSTER First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC)
β
Bazan, F.; Dobi, E.; Villanueva, C.; Nerich, V.; Compagnat, F.; Thiery-Vuillemin
π
Article
π
2011
π
Elsevier Science
π
English
β 41 KB